245 related articles for article (PubMed ID: 19502623)
1. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
Lopes RD; Elliott LE; White HD; Hochman JS; Van de Werf F; Ardissino D; Nielsen TT; Weaver WD; Widimsky P; Armstrong PW; Granger CB
Eur Heart J; 2009 Aug; 30(16):2019-28. PubMed ID: 19502623
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
3. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
[TBL] [Abstract][Full Text] [Related]
5. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.
Guptill JT; Mehta RH; Armstrong PW; Horton J; Laskowitz D; James S; Granger CB; Lopes RD
Circ Cardiovasc Interv; 2013 Apr; 6(2):176-83. PubMed ID: 23549644
[TBL] [Abstract][Full Text] [Related]
6. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
7. Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial.
Mehta RH; Kaul P; Lopes RD; Patel MR; Zheng Y; Pieper KS; Welsh RC; Armstrong PW; Granger CB
Am Heart J; 2012 May; 163(5):797-803. PubMed ID: 22607857
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
Nikolsky E; Mehran R; Dangas GD; Yu J; Parise H; Xu K; Pocock SJ; Stone GW
Am J Cardiol; 2012 Mar; 109(6):831-8. PubMed ID: 22196778
[TBL] [Abstract][Full Text] [Related]
9. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Manzano-Fernández S; Pastor FJ; Marín F; Cambronero F; Caro C; Pascual-Figal DA; Garrido IP; Pinar E; Valdés M; Lip GYH
Chest; 2008 Sep; 134(3):559-567. PubMed ID: 18641090
[TBL] [Abstract][Full Text] [Related]
10. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.
Lopes RD; White JA; Atar D; Keltai M; Kleiman NS; White HD; Widimsky P; Zeymer U; Giugliano RP; Tricoci P; Braunwald E; Bode C; Ohman EM; Armstrong PW; Newby LK
Int J Cardiol; 2013 Oct; 168(3):2510-7. PubMed ID: 23578889
[TBL] [Abstract][Full Text] [Related]
11. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Tjandrawidjaja MC; Fu Y; Westerhout CM; Wagner GS; Granger CB; Armstrong PW;
Am J Cardiol; 2010 Sep; 106(5):630-4. PubMed ID: 20723636
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kinjo K; Sato H; Sato H; Ohnishi Y; Hishida E; Nakatani D; Mizuno H; Fukunami M; Koretsune Y; Takeda H; Hori M;
Am J Cardiol; 2003 Nov; 92(10):1150-4. PubMed ID: 14609587
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction.
Madsen JM; Jacobsen MR; Sabbah M; Topal DG; Jabbari R; Glinge C; Køber L; Torp-Pedersen C; Pedersen F; Sørensen R; Holmvang L; Engstrøm T; Lønborg JT
Am Heart J; 2021 Aug; 238():89-99. PubMed ID: 33957102
[TBL] [Abstract][Full Text] [Related]
15. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
17. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.
De Luca L; Di Lenarda A; Rubboli A; Bolognese L; Gonzini L; Fortuni F; Navazio A; Poletti F; Ledda A; Urbinati S; Gabrielli D; Gulizia MM;
Eur J Intern Med; 2021 Jun; 88():28-34. PubMed ID: 33838988
[TBL] [Abstract][Full Text] [Related]
18. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.
Mrdovic I; Savic L; Krljanac G; Perunicic J; Asanin M; Lasica R; Antonijevic N; Kocev N; Marinkovic J; Vasiljevic Z; Ostojic M
Coron Artery Dis; 2012 Jan; 23(1):1-8. PubMed ID: 22107800
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
Gao F; Zhou YJ; Wang ZJ; Shen H; Liu XL; Nie B; Yan ZX; Yang SW; Jia de A; Yu M
Circ J; 2010 Apr; 74(4):701-8. PubMed ID: 20208381
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing.
Kosmidou I; Liu Y; Zhang Z; Redfors B; Kappetein AP; Serruys PW; Gersh BJ; Kandzari DE; Morice MC; Buszman PE; Bochenek A; Schampaert E; Sabik JF; Ben-Yehuda O; Stone GW
Am J Cardiol; 2020 Feb; 125(4):500-506. PubMed ID: 31813531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
